d-alpha tocopherol has been researched along with Dyskinesia, Drug-Induced in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (6.25) | 18.7374 |
1990's | 37 (57.81) | 18.2507 |
2000's | 18 (28.13) | 29.6817 |
2010's | 4 (6.25) | 24.3611 |
2020's | 1 (1.56) | 2.80 |
Authors | Studies |
---|---|
An, HM; Lv, MH; Shi, J; Soares, JC; Tan, YL; Wang, Z; Yang, F; Zhang, XY; Zhou, D | 1 |
Chen, S; Guan, M; Qin, H; Xu, H | 1 |
Bergman, H; Maayan, N; Soares-Weiser, K | 1 |
An, HM; Kosten, TR; Li, J; Shi, J; Tan, YL; Wang, YC; Wang, ZR; Yang, FD; Zhang, XY; Zhou, DF | 1 |
Abdulwahid Arif, I; Al Kadasah, S; Al Moutaery, K; Al Mutairy, A; Khan, HA; Siddiquei, M; Tariq, M | 1 |
Maayan, N; McGrath, J; Soares-Weiser, K | 1 |
Kuczenski, R; Lohr, JB; Niculescu, AB | 1 |
Abílio, VC; Araujo, CC; Bergamo, M; Calvente, PR; D'Almeida, V; Frussa-Filho, R; Ribeiro, Rde A | 1 |
Bhattachary, SK; Bhattacharya, D; Muruganandam, AV | 1 |
Arolt, V; Erfurth, A; Michael, N; Sourgens, H | 1 |
Adler, LA; Caligiuri, M; Edson, R; Hitzemann, R; Lavori, P; Lohr, J; Raisch, D; Rotrosen, J; Tracy, K | 1 |
Cao, LY; Chen, DC; Wu, GY; Xu, CQ; Zhang, XY; Zhou, DF | 1 |
Jankovic, J; Olanow, CW | 1 |
Abílio, VC; Chinen, CC; D'Almeida, V; de Carvalho, Rde C; de Castro, JP; Faria, RR; Frussa-Filho, R; Fukushiro, DF; Gomes, PH; Grassl, C; Negrão, LT; Registro, S; Ribeiro, Rde A; Rodrigues, MS; Silva, RH | 1 |
Pham, DQ; Plakogiannis, R | 1 |
Chen, JJ; Lee, KC | 1 |
Kotsirilos, V | 1 |
Gattaz, WF | 1 |
al-Deeb, S; al-Moutaery, K; Arshaduddin, M; Bruyn, GW; Evans, DA; Tariq, M | 1 |
Coupland, N; Nutt, O | 1 |
al-Deeb, S; al-Moutairy, K; Arshaduddin, M; Bruyn, GW; Mujeebuddin, S; Tariq, M | 1 |
Adler, LA; Angrist, B; Duncan, E; Lee, M; Peselow, E; Rosenthal, M; Rotrosen, J | 1 |
Laugharne, J; Peet, M; Rangarajan, N; Reynolds, G | 1 |
Adler, LA; Angrist, B; Duncan, E; Peselow, E; Rosenthal, M | 1 |
Dabiri, LM; Darby, JK; Mosbacher, D; Pasta, D | 1 |
Laugharne, J; Peet, M; Rangarajan, N; Reynolds, GP | 1 |
Chiu, HF; Hung, SF; Lam, LC | 1 |
Behrens, S; Emrich, A; Gattaz, WF | 1 |
Schneiderhan, ME | 1 |
Brown, T; D'Alli, R; Doraiswamy, M; Garcia, M; Holmes, VF; Schweickert, L; White, R | 1 |
Corrigan, FM; Horrobin, DF; Mackay, AV; Skinner, ER; Van Rhijn, AG | 1 |
Bunch, CL; Russo, DT | 1 |
Campbell, G; MacDonald, E; McCreadie, RG; Paterson, JR; Wiles, D | 1 |
Caligiuri, MP; Lohr, JB | 1 |
Adams, C; McGrath, J; Soares, K | 1 |
Brown, D; Factor, SA; Molho, ES; Podskalny, GD | 1 |
Ahmad Khan, H; Al-Deeb, S; Al-Moutairy, K; Tariq, M | 1 |
Dorevitch, A; Kalian, M; Lerner, V; Shalfman, M | 1 |
Adler, L; Caligiuri, MP; Edson, R; Lavori, P; Lohr, JB; Rotrosen, J; Tracy, K | 1 |
Lavori, P; Lohr, JB | 1 |
Brown, K; Glen, A; Henderson, T; Hukin, S; Johnstone, C; Reid, A; White, T | 1 |
Adler, LA; Duncan, E; Edson, R; Lavori, P; Peselow, E; Rosenthal, M; Rotrosen, J | 1 |
Sajjad, SH | 1 |
Vatassery, GT | 1 |
Barak, Y; Shamir, E; Stein, D; Swartz, M; Weizman, A | 1 |
Boomershine, JE; Boomershine, KH; Shelton, PS | 1 |
Cathcart, S; Sachdev, P; Saharov, T | 1 |
Elkashef, AM; Wyatt, RJ | 1 |
Simpson, GM | 1 |
McGrath, JJ; Soares, KV | 2 |
Galili, R; Gil-Ad, I; Melamed, E; Offen, D; Weizman, A | 1 |
Bridler, R | 1 |
Glazer, WM; Goff, D; Woods, SW | 1 |
Bhattacharya, D; Bhattacharya, SK; Ghosal, S; Sairam, K | 1 |
Annable, L; Bradwejn, J; Jones, BD; Shriqui, CL | 1 |
Albers, GW; Alexander, RC; Blum, A; Egan, MF; Elkashef, A; Hyde, TM; Reeve, A; Saenz, RE; Wyatt, RJ | 1 |
Radwan, M; Schwartz, B; Spivak, B; Weizman, A | 1 |
Bacher, N; Barrett, D; Elkashef, AM; Ruskin, PE | 1 |
Dommisse, J | 1 |
Cadet, JL; Lohr, JB | 1 |
Cadet, JL; Jeste, DV; Lohr, JB; Lohr, MA; Wyatt, RJ | 1 |
Cadet, JL; Hylton, R; Jeste, DV; Larson, L; Lohr, JB; Lohr, MA; Vidoni, C; Wade, L; Wasli, E; Wyatt, RJ | 1 |
Cadet, JL; Freed, WJ; Lohr, JB; Wyatt, RJ | 1 |
17 review(s) available for d-alpha tocopherol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Tardive Dyskinesia; Vitamin E | 2022 |
Vitamin E for antipsychotic-induced tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Disease Progression; Dyskinesia, Drug-Induced; Humans; Patient Acceptance of Health Care; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Vitamin E; Vitamins | 2018 |
Vitamin E for neuroleptic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Vitamin E; Vitamins | 2011 |
Oxidative mechanisms and tardive dyskinesia.
Topics: Antioxidants; Antipsychotic Agents; Dyskinesia, Drug-Induced; Free Radicals; Humans; Vitamin E | 2003 |
Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Coenzymes; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Indans; Levodopa; Membrane Proteins; N-Methylaspartate; Neuroprotective Agents; Parkinson Disease; Prostaglandin-Endoperoxide Synthases; Ubiquinone; Vitamin E | 2005 |
Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.
Topics: Alzheimer Disease; Antioxidants; Cataract; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Parkinson Disease; Randomized Controlled Trials as Topic; Vitamin E | 2005 |
Nonparkinsonism movement disorders in the elderly.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Aged; Aged, 80 and over; Algorithms; Anticonvulsants; Benzodiazepines; Diagnosis, Differential; Dyskinesia, Drug-Induced; Essential Tremor; Humans; Movement Disorders; Randomized Controlled Trials as Topic; Vitamin E | 2006 |
Vitamin E in tardive dyskinesia.
Topics: Animals; Antioxidants; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Randomized Controlled Trials as Topic; Vitamin E | 1993 |
Cysteamine attenuates iminodipropionitrile (IDPN) induced dyskinesia in rats.
Topics: Animals; Brain; Cysteamine; Dyskinesia, Drug-Induced; Glutathione; Male; Nervous System; Neurotoxins; Nitriles; Rats; Rats, Sprague-Dawley; Vitamin E | 1995 |
Vitamin E and other endogenous antioxidants in the central nervous system.
Topics: Alzheimer Disease; Antioxidants; Central Nervous System; Dyskinesia, Drug-Induced; Humans; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Vitamin E | 1998 |
Vitamin E (alpha-tocopherol) in the treatment of tardive dyskinesia: a statistical meta-analysis.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Middle Aged; Treatment Outcome; Vitamin E | 1998 |
Vitamin E in the treatment of tardive dyskinesia.
Topics: Clinical Trials as Topic; Dyskinesia, Drug-Induced; Free Radical Scavengers; Humans; Vitamin E | 1999 |
Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.
Topics: Antioxidants; Dyskinesia, Drug-Induced; Free Radicals; Humans; Nerve Degeneration; Vitamin E | 1999 |
The treatment of tardive dyskinesia and tardive dystonia.
Topics: Adult; Akathisia, Drug-Induced; Algorithms; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Trees; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Male; Olanzapine; Pirenzepine; Probability; Reserpine; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Tetrabenazine; Treatment Outcome; Vitamin E | 2000 |
Vitamin E for neuroleptic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Psychotic Disorders; Schizophrenia; Vitamin E | 2000 |
Vitamin E for neuroleptic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Vitamin E | 2001 |
Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.
Topics: Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Free Radicals; Humans; Neurotransmitter Agents; Vitamin E | 1989 |
20 trial(s) available for d-alpha tocopherol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Severe tardive dyskinesia in affective disorders: treatment with vitamin E and C.
Topics: Adult; Aged; Ascorbic Acid; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Mood Disorders; Prospective Studies; Vitamin E | 2002 |
Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Longitudinal Studies; Male; Middle Aged; Physical Examination; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; United States; United States Department of Veterans Affairs; Vitamin E | 1999 |
The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
Topics: Adult; Antipsychotic Agents; Capsules; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Radioimmunoassay; Severity of Illness Index; Superoxide Dismutase; Vitamin E | 2004 |
Vitamin E treatment of tardive dyskinesia.
Topics: Ambulatory Care; Antipsychotic Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Hospitalization; Humans; Male; Middle Aged; Placebos; Schizophrenia; Vitamin E | 1993 |
Vitamin E in tardive dyskinesia: time course of effect after placebo substitution.
Topics: Adult; Aged; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Middle Aged; Vitamin E | 1993 |
Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
Topics: Adult; Aged; Ambulatory Care; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Physical Examination; Placebos; Severity of Illness Index; Vitamin E | 1994 |
Vitamin E in the treatment of tardive dyskinesia: a replication study.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Physical Examination; Placebos; Psychiatric Status Rating Scales; Vitamin E | 1994 |
A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
Topics: Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Physical Examination; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Severity of Illness Index; Treatment Outcome; Vitamin E | 1996 |
Lack of effect of vitamin E on serum creatine phosphokinase in patients with long-term tardive dyskinesia.
Topics: Aged; Creatine Kinase; Cross-Over Studies; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Schizophrenia; Time Factors; Vitamin E | 1997 |
Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394.
Topics: Adult; Antioxidants; Dyskinesia, Drug-Induced; Hand Strength; Humans; Reproducibility of Results; Transducers; Vitamin E | 1997 |
Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia.
Topics: Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Lipid Peroxidation; Lipids; Male; Middle Aged; Multivariate Analysis; Schizophrenia; Thiobarbituric Acid Reactive Substances; Vitamin E | 1998 |
Long-term treatment effects of vitamin E for tardive dyskinesia.
Topics: Antioxidants; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Schizophrenia; Time Factors; Vitamin E | 1998 |
Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses.
Topics: Aged; Aged, 80 and over; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Time Factors; Vitamin E | 1998 |
[Vitamin E is ineffective in treatment of late dyskinesias].
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Neurologic Examination; Psychotic Disorders; Treatment Failure; Vitamin E | 2001 |
Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Physical Examination; Placebos; Schizophrenia; Vitamin E | 1992 |
Treatment of tardive dyskinesia with vitamin E.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Free Radical Scavengers; Humans; Mental Disorders; Middle Aged; Physical Examination; Placebos; Vitamin E | 1992 |
alpha-Tocopherol treatment for tardive dyskinesia.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Vitamin E | 1992 |
Vitamin E in the treatment of tardive dyskinesia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Placebos; Psychotic Disorders; Randomized Controlled Trials as Topic; Vitamin E | 1990 |
Alpha-tocopherol in tardive dyskinesia.
Topics: Adult; Aged; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Random Allocation; Vitamin E | 1987 |
Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms.
Topics: Antipsychotic Agents; Brain; Clinical Trials as Topic; Drug Administration Schedule; Dyskinesia, Drug-Induced; Free Radicals; Humans; Peroxides; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Schizophrenic Psychology; Vitamin E | 1988 |
27 other study(ies) available for d-alpha tocopherol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation.
Topics: alpha-Tocopherol; Animals; Antioxidants; Antipsychotic Agents; bcl-2-Associated X Protein; Brain; Disease Models, Animal; Dyskinesia, Drug-Induced; Ginkgo biloba; Haloperidol; Injections, Intraperitoneal; Male; Mastication; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley | 2016 |
Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Free Radical Scavengers; Ginkgo biloba; Haloperidol; Male; Mastication; Plant Extracts; Rats; Rats, Sprague-Dawley; Vitamin E | 2013 |
Pentoxifylline attenuates iminodipropionitrile-induced behavioral abnormalities in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Glutathione; Male; Motor Activity; Neurotoxicity Syndromes; Nitriles; Oxidative Stress; Pentoxifylline; Rats; Rats, Sprague-Dawley; Reflex; Vitamin E | 2009 |
Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Antioxidants; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Glutathione; Injections, Subcutaneous; Male; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Reserpine; Tongue; Vitamin E | 2003 |
Effect of Emblica officinalis tannoids on a rat model of tardive dyskinesia.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Antioxidants; Brain; Disease Models, Animal; Dyskinesia, Drug-Induced; Euphorbiaceae; GABA Modulators; Haloperidol; Male; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Tannins; Valproic Acid; Vitamin E | 2000 |
Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity.
Topics: Animals; Ascorbic Acid; Catalase; Corpus Striatum; Dyskinesia, Drug-Induced; Male; Rats; Rats, Wistar; Reserpine; Vitamin E | 2005 |
Psychotic illness--does complementary medicine have a role in management?
Topics: Antipsychotic Agents; Complementary Therapies; Drugs, Chinese Herbal; Dyskinesia, Drug-Induced; Fatty Acids, Unsaturated; Humans; Music Therapy; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Vitamin E | 2006 |
Does vitamin E prevent tardive dyskinesia?
Topics: Animals; Dyskinesia, Drug-Induced; Male; Oxidative Stress; Rats; Rats, Wistar; Vitamin E | 1995 |
Dipyridamole attenuates the development of iminodipropionitrile-induced dyskinetic abnormalities in rats.
Topics: Animals; Behavior, Animal; Brain Chemistry; Chromatography, High Pressure Liquid; Dipyridamole; Dyskinesia, Drug-Induced; Lipid Peroxides; Male; Neurotoxins; Nitriles; Postural Balance; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet; Vitamin E | 1995 |
Successful treatment of tardive oculogyric spasms with vitamin E.
Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Clopenthixol; Dyskinesia, Drug-Induced; Humans; Male; Schizophrenia; Vitamin E | 1995 |
Effect of selenium and vitamin E on iminodipropionitrile induced dyskinesia in rats.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Drug Synergism; Dyskinesia, Drug-Induced; Injections, Intraperitoneal; Male; Neurotoxins; Rats; Rats, Sprague-Dawley; Selenium; Vitamin E | 1994 |
Tardive dyskinesia.
Topics: Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Neurologic Examination; Vitamin E | 1993 |
Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment.
Topics: Adult; Aged; Dyskinesia, Drug-Induced; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Thiobarbituric Acid Reactive Substances; Vitamin E | 1993 |
Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine; Dyskinesia, Drug-Induced; Grooming; Haloperidol; Male; Rats; Rats, Wistar; Stereotyped Behavior; Vitamin E | 1993 |
Vitamin E treatment of tardive dyskinesia.
Topics: Age Factors; Aged; Dyskinesia, Drug-Induced; Female; Free Radicals; Humans; Male; Research Design; Vitamin E | 1993 |
Vitamin E treatment of tardive dyskinesia.
Topics: Dyskinesia, Drug-Induced; Free Radicals; Humans; Lipid Peroxidation; Vitamin E | 1993 |
Tardive dyskinesia revisited.
Topics: Antipsychotic Agents; Cholinergic Antagonists; Clozapine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Terminology as Topic; Vitamin E | 1995 |
The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cholesterol; Dyskinesia, Drug-Induced; Free Radicals; Health Surveys; Humans; Lipid Peroxidation; Lipid Peroxides; Middle Aged; Neurologic Examination; Reference Values; Schizophrenia; Scotland; Vitamin E | 1995 |
Evidence and tardive dyskinesia.
Topics: Dyskinesia, Drug-Induced; Humans; Randomized Controlled Trials as Topic; Vitamin E | 1996 |
The effect of dancing on dystonia.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dancing; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Psychotic Disorders; Trihexyphenidyl; Vitamin E | 1996 |
Whither vitamin E and tardive dyskinesia?
Topics: Antioxidants; Dyskinesia, Drug-Induced; Humans; Research Design; Vitamin E | 1998 |
The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Delayed-Action Preparations; Disease Models, Animal; Dyskinesia, Drug-Induced; Fluphenazine; Free Radicals; Male; Neuroprotective Agents; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Selegiline; Vitamin E | 1999 |
Haloperidol-induced neurotoxicity--possible implications for tardive dyskinesia.
Topics: Acetylcysteine; Animals; Antipsychotic Agents; Apoptosis; Brain; Cell Survival; Cells, Cultured; Dyskinesia, Drug-Induced; Embryo, Mammalian; Free Radical Scavengers; Haloperidol; Mice; Mice, Inbred ICR; Neurons; PC12 Cells; Rats; Vitamin E | 2000 |
Should Sisyphus have taken melatonin?
Topics: Antioxidants; Dyskinesia, Drug-Induced; Humans; Melatonin; Vitamin E | 2001 |
Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Antioxidants; Disease Models, Animal; Dyskinesia, Drug-Induced; Ergosterol; Glycosides; Haloperidol; Male; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Sitosterols; Solanaceae; Valproic Acid; Vitamin E; Withanolides | 2002 |
Nutritional treatment of tardive dyskinesia.
Topics: Dyskinesia, Drug-Induced; Humans; Niacin; Orthomolecular Therapy; Phosphatidylcholines; Pyridoxine; Vitamin E; Vitamins | 1991 |
Partial reversal of the iminodipropionitrile-induced hyperkinetic syndrome in rats by alpha-tocopherol (vitamin E).
Topics: Animals; Disease Models, Animal; Dyskinesia, Drug-Induced; Male; Nitriles; Rats; Rats, Inbred Strains; Vitamin E | 1988 |